Kairos Pharma Ltd.
KAPA | AMEX
$1.71
-$0.08 (-4.47%)
Sep 22, 2026, 11:33 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -1.39M | -1.65M | -1.37M | -1.4M | -1.42M | -1.26M | -980K | -1.05M | -253K | -323K | -1.12M | -312K | -236K | -146K | -196K | -234K | -385K | -235K |
Depreciation & Amortization | 22K | 40K | 40K | 40K | 40K | 40K | 40K | 40K | 40K | 40K | 40K | 40K | 40K | 40K | 40K | 40K | 40K | 40K |
Stock-Based Compensation | 259K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 198K | -92K | -230K | -210K | -669K | 432K | -610K | -1.7M | 26K | 299K | 205K | 353K | 118K | 88K | 77K | 52K | 11K | -11K |
Other Non-Cash Items | 22K | 479K | 471K | 730K | 1.38M | 76K | -253K | 686K | 19K | 20K | 939K | 10K | 10K | 10K | 10K | 90K | 250K | 58K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 73K | 99K | -230K | -210K | -798K | 432K | -610K | -1.7M | 26K | 299K | 205K | 353K | 118K | 88K | 77K | 52K | 11K | -11K |
Operating Cash Flow | -1.01M | -1.04M | -1.08M | -838K | -805K | -714K | -1.8M | -2.02M | -168K | 36K | 66K | 91K | -68K | -8K | -69K | -52K | -84K | -148K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | 248K | -350K | 102K | n/a | n/a | n/a | n/a | n/a | n/a | 206K | 328K | 250K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -44K | n/a | n/a | 3.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10K |
Financial Cash Flow | -37K | 220K | n/a | 3.38M | 223K | 3.06M | -142K | 5.22M | 149K | -89K | -72K | -224K | -57K | -72K | -17K | 191K | 303K | 240K |
Net Cash Flow | -1.05M | -816K | -1.08M | 2.54M | -582K | 2.34M | -1.95M | 3.2M | -19K | -53K | -6K | -133K | -125K | -80K | 437K | n/a | n/a | n/a |
Free Cash Flow | -1.01M | -1.04M | -1.08M | -838K | -805K | -714K | -1.8M | -2.02M | -168K | 36K | 66K | 91K | -68K | -8K | -69K | -52K | -84K | -148K |
Adj. Free Cash Flow | -1.27M | -1.04M | -1.08M | -838K | -805K | -714K | -1.8M | -2.02M | -168K | 36K | 66K | 91K | -68K | -8K | -69K | -52K | -84K | -148K |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | n/a | n/a | n/a | n/a |
Owner Earnings | -1.01M | -1.04M | -1.08M | -838K | -805K | -714K | -1.8M | -2.02M | -168K | 36K | 66K | 91K | -68K | -8K | -69K | -52K | -84K | -148K |
Add to Watchlist
Select watchlists to add or remove KAPA